Prognosis in antiphospholipid syndrome (Q34354761)

1 August 2017

1 reference

title

Prognosis in antiphospholipid syndrome (English)

1 reference

1 August 2017

Amigo MC

1

1 reference

1 August 2017

publication date

1 August 2001

1 reference

Rheumatic Diseases Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

27

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

661-669

1 reference

The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Widespread cutaneous necrosis and antiphospholipid antibodies: two episodes related to surgical manipulation and urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

The ‘Primary’ Antiphospholipid Syndrome: Antiphospholipid Antibody Pattern and Clinical Features of a Series of 23 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Thrombosis, abortion, cerebral disease, and the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Lupus anticoagulant as a prognostic marker in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Lethal pulmonary embolism in a patient with primary antiphospholipid syndrome and a vena caval filter

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Frequent hemodialysis graft thrombosis: association with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Lower limb ischaemia in primary antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Primary antiphospholipid syndrome associated with postoperative primary adrenal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Antiphospholipid antibodies and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Frequency, potential risk and therapeutic intervention in end-stage renal disease patients with antiphospholipid antibody syndrome: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970227-1

7 January 2021

10.1016/S0889-857X(05)70227-1

Identifiers

DOI

1 reference

release_x65tbc6mrfbpphbx3x5ntmvjou

1 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/x65tbc6mrfbpphbx3x5ntmvjou

24 November 2022

mapped directly with Wikidata item

1 reference